These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 27786004)

  • 1. Effects of Prostaglandin Synthetase Inhibitation on Captopril-Induced Changes in Renal Function in Bartter's Syndrome.
    Rudin A; Granérus G; Aurell M
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):59-62. PubMed ID: 27786004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin synthetase inhibition on captopril-induced changes in renal function in Bartter's syndrome.
    Rudin A; Granérus G; Aurell M
    Scand J Urol Nephrol Suppl; 1984; 79():59-62. PubMed ID: 6433438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's syndrome.
    Aurell M; Rudin A
    Nephron; 1983; 33(4):274-8. PubMed ID: 6341865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bartter's syndrome: renal scintigraphic appearance after captopril administration.
    Dondi M; Fanti S; Monetti N
    J Nucl Med; 1996 Oct; 37(10):1688-90. PubMed ID: 8862312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in plasma inactive renin levels in Bartter's syndrome after administration of captopril and angiotensin II.
    Nagai H; Matsunaga M; Ogawa K; Pak CH; Kanatsu K; Hara A; Kono T; Kawai C
    Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):69-75. PubMed ID: 3519017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome and captopril scintigraphy: a case report.
    Colamussi P; Panareo S; Cittanti C; Giganti M; Filice A; Baresic T; El Maoued S; Rizzati R; Piffanelli A
    Ann Nucl Med; 2003 Apr; 17(2):149-52. PubMed ID: 12790365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome.
    Jest P; Pedersen KE; Klitgaard NA; Thomsen N; Kjaer K; Simonsen E
    Eur J Clin Pharmacol; 1991; 41(4):303-5. PubMed ID: 1804643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactive renin and aldosterone in Bartter's syndrome.
    McKenzie IM; Heiman D; Winter JS; McKenzie JK
    Clin Invest Med; 1987 Jul; 10(4):303-8. PubMed ID: 3308240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril renography in Bartter's syndrome.
    Suzuki T; Nangaku M; Oku S; Takemura H; Yokoyama Y; Takahashi Y; Fujita T
    Clin Exp Nephrol; 2002 Sep; 6(3):163-5. PubMed ID: 24989957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma "prorenin"-renin in Bartter's syndrome, cystic fibrosis, and chloride deficiency, and the effect of prostaglandin synthetase inhibition.
    Chan LL; Osmond DH; Balfe JW; Halperin ML
    J Lab Clin Med; 1981 Jun; 97(6):785-90. PubMed ID: 6785370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
    Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
    Romero JC; Strong CG
    Mayo Clin Proc; 1977 Jul; 52(7):462-4. PubMed ID: 875471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.